Background: Self-expanding metal stents are frequently used for the palliation of malignant dysphagia. Recently, a new stent design, the Evolution stent (Cook Medical, Limerick, Ireland), was developed. The stent has an internal and external silicone coating to resist tissue ingrowth and uncoated dual flanges on both ends to prevent migration. Its controlled-release system may allow full control and precise positioning of the stent. Objective: To determine the safety and clinical effectiveness of the Evolution stent for the palliation of dysphagia in patients with malignant strictures located in the esophagus (n = 33 [75%]) or gastric cardia (n = 11 [25%]). Methods: All patients who underwent placement of an esophageal Evolution stent from ...
The purpose of this study was to determine the efficacy of the uncovered coil stents in patients wit...
INTRODUCTION: Stent migration is a significant clinical problem in palliation of malignant stricture...
Background and study aims: In patients with primary esophageal cancer, luminal patency can be restor...
Background: Self-expanding metal stents are frequently used for the palliation of malignant dysphagi...
Background: Fully covered stents are designed to resist tissue ingrowth that is often seen with part...
Background: The majority of the Currently available metal stents are partially covered to reduce mig...
BACKGROUND & AIM: Stents are often used for the palliation of inoperable esophageal or gastric c...
OBJECTIVES: Self-expanding metal stents (SEMS) provide effective palliation in patients with maligna...
Abstract: OBJECTIVES: Self-expanding metal stents (SEMS) provide effective palliation in patients wi...
Self-expanding metal stents (SEMSs) in different geometric shapes are an established palliative trea...
Abstract: OBJECTIVES: Self-expanding metal stents (SEMS) provide effective palliation in patients wi...
Advanced esophageal carcinoma has a rather dismal prognosis with dysphagia to solids and liquids as ...
Objective Dysphagia is the most distressing symptom in patients with cancer-related oesophageal obst...
Background: Use of large caliber [≥18 mm body diameter (BD)] self-expanding metal stents (SEMS) for ...
The purpose of this study was to determine the efficacy of the uncovered coil stents in patients wit...
The purpose of this study was to determine the efficacy of the uncovered coil stents in patients wit...
INTRODUCTION: Stent migration is a significant clinical problem in palliation of malignant stricture...
Background and study aims: In patients with primary esophageal cancer, luminal patency can be restor...
Background: Self-expanding metal stents are frequently used for the palliation of malignant dysphagi...
Background: Fully covered stents are designed to resist tissue ingrowth that is often seen with part...
Background: The majority of the Currently available metal stents are partially covered to reduce mig...
BACKGROUND & AIM: Stents are often used for the palliation of inoperable esophageal or gastric c...
OBJECTIVES: Self-expanding metal stents (SEMS) provide effective palliation in patients with maligna...
Abstract: OBJECTIVES: Self-expanding metal stents (SEMS) provide effective palliation in patients wi...
Self-expanding metal stents (SEMSs) in different geometric shapes are an established palliative trea...
Abstract: OBJECTIVES: Self-expanding metal stents (SEMS) provide effective palliation in patients wi...
Advanced esophageal carcinoma has a rather dismal prognosis with dysphagia to solids and liquids as ...
Objective Dysphagia is the most distressing symptom in patients with cancer-related oesophageal obst...
Background: Use of large caliber [≥18 mm body diameter (BD)] self-expanding metal stents (SEMS) for ...
The purpose of this study was to determine the efficacy of the uncovered coil stents in patients wit...
The purpose of this study was to determine the efficacy of the uncovered coil stents in patients wit...
INTRODUCTION: Stent migration is a significant clinical problem in palliation of malignant stricture...
Background and study aims: In patients with primary esophageal cancer, luminal patency can be restor...